Increased expression of thisfactor results in increasing growth and survivalof myeloma cells, their attachment to bone marrowstromal cells, tumor formation and VEGFsecretion through targeting CCND1, integrin β7,and CCR1 (chemokine receptor) genes. Here, CCND1 is linked to plasma cell myeloma.